Targeted adalimumab treatment can optimize long-term outcomes for patients with early RA
Links shared publicly online about this topic.
- 267total visits
Targeted adalimumab treatment can optimize long-term outcomes for patients with early RA
View full resource at medicalxpress.com
Tags: Crohn's Disease Medication, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Humira, Rheumatrex, Trexall, Folex PFS
Most Recently Shared on May 25, 2011 at 2:17 pm By:
Targeted adalimumab treatment can optimize long-term outcomes for patients with early RA http://tw.medicalxpress.com/225537124
Targeted adalimumab treatment can optimize long-term outcomes for patients with early rheumatoid arthritis, study suggests
sciencedaily.com — “New research shows that initial treatment with adalimumab (Humira, ADA) plus methotrexate in early RA patients can provide high levels of disease control in many patients, and may also offer the opportunity to change future treatment options for some.” View full resource at sciencedaily.com
Most Recently Shared on May 26, 2011 at 3:54 pm By:
Targeted adalimumab treatment can optimize long-term outcomes for patients with early rheumatoid arthritis, stud... http://bit.ly/iQuQlm
Advertisement
